VRDN: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Segment research and development expense	233,544	-
Segment general and administrative expense	45,165	-
Share-based compensation expense (see note 10)	32,314	-
License revenue-License	70,000	-
Other items	-18,777	-
Net loss	-222,246	-187,647
Share-based compensation expense	32,314	21,064
Non-cash interest expense	308	-
Depreciation and amortization	340	230
Non-cash interest expense and amortization of debt issuance costs	-	206
Accretion and amortization of available-for-sale securities	5,005	3,872
Non-cash lease expense	-30	-17
Deferred revenue - related party	-	-144
Net loss on disposal of equipment	0	-
Unbilled revenue	70,000	0
Prepaid expenses and other assets	-8,849	-5,479
Accounts payable	7,942	6,396
Accrued and other liabilities	-5,109	-9,721
Net cash used in operating activities	-252,637	-168,026
Purchases of short-term investments	141,084	126,998
Maturities of short-term investments	443,196	302,906
Purchase of property and equipment	255	128
Net cash provided by (used in) investing activities	301,857	175,780
Proceeds from the issuance of common stock-September2022ATMAgreement	-	4,944
Proceeds from sale of common stock in public offering	0	-
Proceeds from the issuance of common stock-January2024Public Offering	-	0
Proceeds from sale of common stock in at-the-market offerings	14,904	-
Payments of issuance costs associated with sale of common stock-Common Stock	416	207
Proceeds from the issuance of series b preferred stock, pursuant to september 2024 public offering	0	-
Payments of issuance costs associated with sale of common stock-Preferred Stock	0	-
Proceeds from issuance of common stock upon exercises of warrants	1,618	1,618
Proceeds from issuance of common stock upon exercises of stock options	3,607	3,060
Proceeds from issuance of common stock under employee stock purchase plan	1,120	561
Net cash provided by financing activities	20,833	9,976
Net increase in cash and cash equivalents	70,053	17,730
Cash and cash equivalents at beginning of period	99,594	-
Cash and cash equivalents at end of period	169,647	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

VRDN: the cashflow